Small Molecules

04 May 2007 Xanthus Presents Novel Approach for Autoimmune Disease Reversal with Symadex
04 May 2007 Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device Combination Product - ChronoDose
04 May 2007 Alpharma Presents Positive Pharmacokinetic Study Results of Its Investigational Abuse-Deterrent, Extended-Release Opioid
04 May 2007 CyDex Licenses Captisol(R) to Sunesis Pharmaceuticals for Oncology Drug Candidate
03 May 2007 Neurogen Announces Results of First-in-Human Trial for New Approach to Treating Obesity
03 May 2007 Phase III Data on Safinamide in Parkinson's Disease Presented at American Academy of Neurology 59th Annual Meeting
03 May 2007 Spectrum Pharmaceuticals Initiates Phase 3, Registrational Trials With EOquin(R) in Non-Invasive Bladder Cancer
03 May 2007 Last Patient Treated in First Pivotal TH9507 Study
03 May 2007 BioMarin Initiates Phase 2a Clinical Study of 6R-BH4 in Sickle Cell Disease
03 May 2007 FDA Approves Oscient Pharmaceuticals' FACTIVE(R) Tablets for Five-Day Treatment of Community-Acquired Pneumonia
03 May 2007 Sunesis Pharmaceuticals Announces Preclinical Milestone Payment in BACE Collaboration with Merck
03 May 2007 Next Pharmaceuticals Reveals Nexrutine(R) Prevents Prostate Cancer Progression in Pre-clinical Animal Model
03 May 2007 FDA Approves FRAGMIN(R) as First Low-Molecular-Weight Heparin for Extended Treatment to Reduce the Recurrence of Blood Clots in Patients with Cancer
03 May 2007 Genelabs Technologies Announces Presentation of Data on Non-Nucleoside HCV Polymerase Inhibitor at 20th International Conference on Antiviral Research Meeting
03 May 2007 Acorda Therapeutics Presents Data from its Phase 3 Study of Fampridine-SR in Multiple Sclerosis at the American Academy of Neurology Meeting
03 May 2007 Anadys Presents Results From Its NS5b HCV Program at International Conference on Antiviral Research
03 May 2007 YM Biosciences Reports Aerolef(TM) Randomized Phase Iib Trial Meets Primary Endpoint In Patients With Post-Surgical Pain
02 May 2007 Up and down with cholesterol management
02 May 2007 deCODE Announces Positive Topline Results for Phase I Study of DG051 for the Prevention of Heart Attack
02 May 2007 Trigen's innovative platelet adhesion inhibitor, PR-15, successfully completes first-in-man Phase I study
02 May 2007 Sciele Pharma Signs Exclusive License Agreement with LifeCycle Pharma A/S To Market a New Formulation of Fenofibrate in 120 mg and 40 mg Dosage Strengths
02 May 2007 Acusphere Announces Positive Results from Pivotal Phase 3 Clinical Trial of Imagify(TM)
02 May 2007 Transport Pharmaceuticals Initiates Patient Enrollment In Phase 2 Study Of Solovir System For Herpes Labialis
02 May 2007 Hollis-Eden Pharmaceuticals Cleared by FDA to Initiate Phase I Clinical Trial with HE3286 in Treating Metabolic Disorders
02 May 2007 Laquinimod, a Novel Oral Compound, Showed Significant Reduction in Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS)

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up